SCHEMBL3826599

SCHEMBL3826599

CNc1ccc(-c2[nH]c(-c3ccccc3/C=C/C(=O)OC)nc2-c2ccc(N(CCOC)CCOC)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ FABP4 P15090 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MGAM O43451 1/20 0.36
▸ RAF1 P04049 1/20 0.35
▸ CCNC P24863 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ NOX1 Q9Y5S8 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ TEK Q02763 1/20 0.35
▸ MPO P05164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13679673 0.84 PTPN1 (0.43) MEN1KMT2AKDM4ERAF1NOX1
SCHEMBL6608185 0.82 RAF1 (0.43) MEN1KMT2APOLBFABP4KDM4E
SCHEMBL3824756 0.80 SELP (0.40) MEN1KMT2APOLBFABP4KDM4E
SCHEMBL3824754 0.79 ALOX5 (0.41) MEN1KMT2APOLBKDM4ENOX1
SCHEMBL3824090 0.79 SELP (0.41) MEN1KMT2APOLBFABP4KDM4E
SCHEMBL3829650 0.79 RAF1 (0.39) MEN1KMT2APOLBKDM4EMGAM
SCHEMBL3824183 0.67 NOX1 (0.45) MEN1KMT2APOLBKDM4EMGAM
SCHEMBL3828923 0.66 NOX1 (0.40) MEN1KMT2AKDM4ENOX1ALDH1A1
SCHEMBL32673048 0.66 PTPN1 (0.52) MEN1KMT2AKDM4ERAF1NOX1
SCHEMBL13679655 0.64 PTPN1 (0.46) MEN1KMT2AKDM4ERAF1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
EP-0999835-A4 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORP (US) 2004-08-25 — — EP disclosed
EP-0999835-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS Ontogen Corporation (US) 2000-05-17 — — EP disclosed
WO-1999002155-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORPORATION (US) 1999-01-21 — — WO disclosed
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 — — US disclosed
Send feedback